Clinical trials
Lupus Erythematosus, Systemic trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
164 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 8 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 12 |
| 2019 | 5 |
| 2020 | 12 |
| 2021 | 11 |
| 2022 | 12 |
| 2023 | 18 |
| 2024 | 9 |
| 2025 | 13 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 82 |
| Recruiting | 35 |
| Active, not recruiting | 18 |
| Terminated | 12 |
| Not yet recruiting | 6 |
| Unknown status | 6 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 19 |
| AstraZeneca | 8 |
| Novartis Pharmaceuticals | 8 |
| University Hospital, Bordeaux | 8 |
| Bristol-Myers Squibb | 6 |
| GlaxoSmithKline | 6 |
| Amgen | 5 |
| Eli Lilly and Company | 5 |
| UCB Pharma | 5 |
| University Hospital, Montpellier | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 164 |
| Autoimmune Diseases | 27 |
| Arthritis, Rheumatoid | 24 |
| Lupus Nephritis | 19 |
| Scleroderma, Systemic | 14 |
| Sjogren's Syndrome | 11 |
| Myositis | 10 |
| Connective Tissue Diseases | 9 |
| Immune System Diseases | 9 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 |
Trials
Showing 76 to 100 of 164. Each trial links to its page on Pharma Observatory.
64 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.